Other Clinical Trial - Outreach Core Activities

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Recruiting

Clinical Trial Summary

The Ponce Health Sciences University-Moffitt Cancer Center (PSHU-MCC) U54 Outreach Core (OC) goal is to increase community cancer awareness, community engagement (CE) and participation in cancer health disparities research and outreach in Hispanic/Latino communities through the following: Aim 1: To develop, deliver, and disseminate cancer education and outreach activities to Hispanic/Latino community members to reduce cancer health disparities. Aim 2: To enhance capacity for mutually beneficial research engagement to address cancer health disparities. Aim 3: To expand the capacity to train community members as lay health promoters to deliver evidenced-based cancer education programs in their communities.

Clinical Trial Description

n/a

Study Design

Clinical Trial Details

NCT number	NCT05832177
Study type	Observational
Source	H. Lee Moffitt Cancer Center and Research Institute
Contact	Shannon Christy, PhD
Phone	813-745-8840
Email	Shannon.Christy@moffitt.org
Status	Recruiting
Phase
Start date	March 22, 2023
Completion date	July 2028

View Details